AXA (EPA:CS) Given a €29.50 Price Target at Royal Bank of Canada
Royal Bank of Canada set a €29.50 ($34.30) price objective on AXA (EPA:CS) in a report released on Tuesday morning, Borsen Zeitung reports. The firm currently has a buy rating on the stock.
Several other brokerages also recently commented on CS. HSBC lowered their price objective on Canada Goose from C$62.00 to C$55.00 and set a buy rating on the stock in a research report on Monday, June 3rd. Barclays boosted their price objective on Zimmer Biomet from $113.00 to $117.00 and gave the company an underweight rating in a research report on Monday, April 15th. Deutsche Bank lowered their price objective on from GBX 217 ($2.84) to GBX 175 ($2.29) and set a sell rating on the stock in a research report on Monday, June 24th. UBS Group set a $125.00 price objective on Caterpillar and gave the company a sell rating in a research report on Friday, May 3rd. Finally, Goldman Sachs Group restated a hold rating and issued a $8.40 price objective on shares of Deutsche Bank in a research report on Monday, July 8th. Four investment analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The stock currently has an average rating of Buy and a consensus target price of €26.56 ($30.89).
Shares of AXA stock opened at €23.66 ($27.51) on Tuesday. The firm has a 50-day simple moving average of €22.87. AXA has a 52 week low of €22.13 ($25.73) and a 52 week high of €27.69 ($32.20).
AXA SA, through its subsidiaries, provides insurance and asset management services worldwide. It operates in seven segments: France, Europe, Asia, AXA XL, the United States, International, and Transversal & Central Holdings. The company offers a range of insurance products, including life and savings, property and casualty, and health.
Featured Article: Lock-Up Period Expiration
Receive News & Ratings for AXA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXA and related companies with MarketBeat.com's FREE daily email newsletter.